Novo Nordisk To Up Production Capacity As Parent Buys Catalent
Shares in Novo Nordisk rose after its parent, Novo Holdings, said it has agreed to by contract drug manufacturer Catalent for $11.5 billion in cash.
Full Article
Novo Nordisk To Up Production Capacity As Parent Buys Catalent
Upworthy
0 shares
1 views
You might like
Related news coverage
Astrazeneca says Catalent deal shows need for in-house capacity
Upworthy
The sale of listed contract drugmaker Catalent to the parent of Novo Nordisk this week demonstrates the importance for big pharma..
-
Novo Holdings to purchase drug manufacturer Catalent for $16.5 billion, a deal that could expand Wegovy production
Upworthy
-
Novo Nordisk Drops $11 Billion to Expand Weight-Loss Drug Production
Upworthy
-
Novo Nordisk parent buys US drug firm for $16.5bn to expand Wegovy supply
Upworthy
-
Wegovy maker Novo inks $16.5 billion acquisition of Catalent to boost supply
Upworthy